Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/259274
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis |
Autor: | Burgaz, Sonia; García, Concepción; Gonzalo-Consuegra, Claudia; Gómez-Almería, Marta; Ruiz-Pino, Francisco; Unciti, Juan Diego; Gómez-Cañas, María; Alcalde, Juan CSIC ORCID ; Morales,Paula; Jagerovic, Nadine CSIC ORCID ; Rodríguez-Cueto, Carmen; Lago, Eva de; Muñoz, Eduardo CSIC; Fernández-Ruiz, Javier | Palabras clave: | Cannabinoids GPR55 receptors VCE-006.1 Chromenopyrazole Parkinson’s disease 6-hydroxydopamine Lipopolysaccharide Amyotrophic lateral sclerosis mSOD1 mice TDP-43 transgenic mice |
Fecha de publicación: | dic-2021 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Molecules 26(24) : 76432021 (2021) | Resumen: | Cannabinoids act as pleiotropic compounds exerting, among others, a broad-spectrum of neuroprotective effects. These effects have been investigated in the last years in different preclinical models of neurodegeneration, with the cannabinoid type-1 (CB1) and type-2 (CB2) receptors concen- trating an important part of this research. However, the issue has also been extended to additional targets that are also active for cannabinoids, such as the orphan G-protein receptor 55 (GPR55). In the present study, we investigated the neuroprotective potential of VCE-006.1, a chromenopyrazole derivative with biased orthosteric and positive allosteric modulator activity at GPR55, in murine models of two neurodegenerative diseases. First, we proved that VCE-006.1 alone could induce ERK1/2 activation and calcium mobilization, as well as increase cAMP response but only in the presence of lysophosphatidyl inositol. Next, we investigated this compound administered chronically in two neurotoxin-based models of Parkinson’s disease (PD), as well as in some cell-based models. VCE-006.1 was active in reversing the motor defects caused by 6-hydroxydopamine (6-OHDA) in the pole and the cylinder rearing tests, as well as the losses in tyrosine hydroxylase-containing neurons and the elevated glial reactivity detected in the substantia nigra. Similar cytoprotective effects were found in vitro in SH-SY5Y cells exposed to 6-OHDA. We also investigated VCE-006.1 in LPS-lesioned mice with similar beneficial effects, except against glial reactivity and associated inflammatory events, which remained unaltered, a fact confirmed in BV2 cells treated with LPS and VCE-006.1. We also analyzed GPR55 in these in vivo models with no changes in its gene expression, although GPR55 was down-regulated in BV2 cells treated with LPS, which may explain the lack of efficacy of VCE-006.1 in such an assay. Furthermore, we investigated VCE-006.1 in two genetic models of amyotrophic lateral sclerosis (ALS), mutant SOD1, or TDP-43 transgenic mice. Neither the neurological decline nor the deteriorated rotarod performance were prevented with this compound, and the same happened with the elevated microglial and astroglial reactivities, albeit modest spinal motor neuron preservation was achieved in both models. We also analyzed GPR55 in these in vivo models and found no changes in both TDP-43 transgenic and mSOD1 mice. Therefore, our findings support the view that targeting the GPR55 may afford neuroprotection in experimental PD, but not n ALS, thus stressing the specificities for the development of cannabinoid-based therapies in the different neurodegenerative disorders. | Versión del editor: | https://doi.org/10.3390/molecules2624764 | URI: | http://hdl.handle.net/10261/259274 | DOI: | 10.3390/molecules26247643 |
Aparece en las colecciones: | (IQM) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
molecules-26-07643-v2-1-1.pdf | Artículo principal | 15,24 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
11
checked on 24-abr-2024
WEB OF SCIENCETM
Citations
9
checked on 22-feb-2024
Page view(s)
48
checked on 24-abr-2024
Download(s)
102
checked on 24-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.